233 related articles for article (PubMed ID: 22867097)
1. Inhibition of human topoisomerases I and II by simocyclinone D8.
Oppegard LM; Nguyen T; Ellis KC; Hiasa H
J Nat Prod; 2012 Aug; 75(8):1485-9. PubMed ID: 22867097
[TBL] [Abstract][Full Text] [Related]
2. Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors.
Verghese J; Nguyen T; Oppegard LM; Seivert LM; Hiasa H; Ellis KC
Bioorg Med Chem Lett; 2013 Nov; 23(21):5874-7. PubMed ID: 24060488
[TBL] [Abstract][Full Text] [Related]
3. An improved assay for the detection of alterations in bacterial DNA supercoiling in vivo.
Abu Mraheil M; Heisig A; Heisig P
Pharmazie; 2013 Jul; 68(7):541-8. PubMed ID: 23923635
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro patterns of the activity of simocyclinone D8, an angucyclinone antibiotic from Streptomyces antibioticus.
Oppegard LM; Hamann BL; Streck KR; Ellis KC; Fiedler HP; Khodursky AB; Hiasa H
Antimicrob Agents Chemother; 2009 May; 53(5):2110-9. PubMed ID: 19273673
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of topopyrones.
Zaleski PA; Maini R; Leiris SJ; Elban MA; Hecht SM
J Nat Prod; 2012 Apr; 75(4):577-85. PubMed ID: 22462811
[TBL] [Abstract][Full Text] [Related]
6. New topoisomerases inhibitors: synthesis of rutaecarpine derivatives and their inhibitory activity against topoisomerases.
Kim SI; Lee SH; Lee ES; Lee CS; Jahng Y
Arch Pharm Res; 2012 May; 35(5):785-9. PubMed ID: 22644846
[TBL] [Abstract][Full Text] [Related]
7. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor.
Dalla Via L; Marzaro G; Ferrarese A; Gia O; Chilin A
Eur J Med Chem; 2014 Apr; 77():103-9. PubMed ID: 24631729
[TBL] [Abstract][Full Text] [Related]
8. Coupling of the biosynthesis and export of the DNA gyrase inhibitor simocyclinone in Streptomyces antibioticus.
Le TB; Fiedler HP; den Hengst CD; Ahn SK; Maxwell A; Buttner MJ
Mol Microbiol; 2009 Jun; 72(6):1462-74. PubMed ID: 19460097
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase I/II inhibition by a novel naphthoquinone containing a modified anthracycline ring system.
Kennedy S; DiCesare JC; Sheaff RJ
Biochem Biophys Res Commun; 2011 Apr; 408(1):94-8. PubMed ID: 21458415
[TBL] [Abstract][Full Text] [Related]
11. Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action.
Flatman RH; Howells AJ; Heide L; Fiedler HP; Maxwell A
Antimicrob Agents Chemother; 2005 Mar; 49(3):1093-100. PubMed ID: 15728908
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Thapa U; Thapa P; Karki R; Yun M; Choi JH; Jahng Y; Lee E; Jeon KH; Na Y; Ha EM; Cho WJ; Kwon Y; Lee ES
Eur J Med Chem; 2011 Aug; 46(8):3201-9. PubMed ID: 21601964
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
Yao BL; Mai YW; Chen SB; Xie HT; Yao PF; Ou TM; Tan JH; Wang HG; Li D; Huang SL; Gu LQ; Huang ZS
Eur J Med Chem; 2015 Mar; 92():540-53. PubMed ID: 25599951
[TBL] [Abstract][Full Text] [Related]
15. A new crystal structure of the bifunctional antibiotic simocyclinone D8 bound to DNA gyrase gives fresh insight into the mechanism of inhibition.
Hearnshaw SJ; Edwards MJ; Stevenson CE; Lawson DM; Maxwell A
J Mol Biol; 2014 May; 426(10):2023-33. PubMed ID: 24594357
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of benzo-annulated tryptanthrins and their biological properties.
Liang JL; Park SE; Kwon Y; Jahng Y
Bioorg Med Chem; 2012 Aug; 20(16):4962-7. PubMed ID: 22819942
[TBL] [Abstract][Full Text] [Related]
17. Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrB.
Sissi C; Vazquez E; Chemello A; Mitchenall LA; Maxwell A; Palumbo M
Antimicrob Agents Chemother; 2010 Jan; 54(1):213-20. PubMed ID: 19858260
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.
Genès C; Lenglet G; Depauw S; Nhili R; Prado S; David-Cordonnier MH; Michel S; Tillequin F; Porée FH
Eur J Med Chem; 2011 Jun; 46(6):2117-31. PubMed ID: 21435753
[TBL] [Abstract][Full Text] [Related]
19. Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells.
Pan X; Hartley JM; Hartley JA; White KN; Wang Z; Bligh SW
Phytomedicine; 2012 May; 19(7):618-24. PubMed ID: 22402246
[TBL] [Abstract][Full Text] [Related]
20. Rational design, synthesis, and evaluation of novel 2,4-Chloro- and Hydroxy-Substituted diphenyl Benzofuro[3,2-b]Pyridines: Non-intercalative catalytic topoisomerase I and II dual inhibitor.
Park S; Thapa Magar TB; Kadayat TM; Lee HJ; Bist G; Shrestha A; Lee ES; Kwon Y
Eur J Med Chem; 2017 Feb; 127():318-333. PubMed ID: 28068603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
